scholarly journals Self-reconstructing Bessel beam created by two-photon-polymerized micro-axicon for light-sheet fluorescence microscopy

2021 ◽  
pp. 104111
Author(s):  
Shufan Li ◽  
Jiannan Jiao ◽  
Jeeranan Boonruangkan ◽  
Hui Ting Toh ◽  
Jianing An ◽  
...  
2018 ◽  
Vol 16 (11) ◽  
pp. 111801 ◽  
Author(s):  
Suhui Deng Suhui Deng ◽  
Yiping Xiao Yiping Xiao ◽  
Jie Hu Jie Hu ◽  
Jianfang Chen Jianfang Chen ◽  
Yuhao Wang Yuhao Wang ◽  
...  

2020 ◽  
Vol 28 (7) ◽  
pp. 9464 ◽  
Author(s):  
Bo Xiong ◽  
Xiaofei Han ◽  
Jiamin Wu ◽  
Hao Xie ◽  
Qionghai Dai

2021 ◽  
Vol 9 ◽  
Author(s):  
Yu-Xuan Ren ◽  
Hongsen He ◽  
Huajun Tang ◽  
Kenneth K. Y. Wong

The light propagation in the medium normally experiences diffraction, dispersion, and scattering. Studying the light propagation is a century-old problem as the photons may attenuate and wander. We start from the fundamental concepts of the non-diffracting beams, and examples of the non-diffracting beams include but are not limited to the Bessel beam, Airy beam, and Mathieu beam. Then, we discuss the biomedical applications of the non-diffracting beams, focusing on linear and nonlinear imaging, e.g., light-sheet fluorescence microscopy and two-photon fluorescence microscopy. The non-diffracting photons may provide scattering resilient imaging and fast speed in the volumetric two-photon fluorescence microscopy. The non-diffracting Bessel beam and the Airy beam have been successfully used in volumetric imaging applications with faster speed since a single 2D scan provides information in the whole volume that adopted 3D scan in traditional scanning microscopy. This is a significant advancement in imaging applications with sparse sample structures, especially in neuron imaging. Moreover, the fine axial resolution is enabled by the self-accelerating Airy beams combined with deep learning algorithms. These additional features to the existing microscopy directly realize a great advantage over the field, especially for recording the ultrafast neuronal activities, including the calcium voltage signal recording. Nonetheless, with the illumination of dual Bessel beams at non-identical orders, the transverse resolution can also be improved by the concept of image subtraction, which would provide clearer images in neuronal imaging.


2012 ◽  
Vol 3 (7) ◽  
pp. 1492 ◽  
Author(s):  
Omar E. Olarte ◽  
Jacob Licea-Rodriguez ◽  
Jonathan A. Palero ◽  
Emilio J. Gualda ◽  
David Artigas ◽  
...  

2015 ◽  
Vol 108 (2) ◽  
pp. 326a ◽  
Author(s):  
Giuseppe Sancataldo ◽  
Zeno Lavagnino ◽  
Marta d’Amora ◽  
Francesca Cella Zanacchi ◽  
Alberto Diaspro

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Stefanie Schwinn ◽  
Zeinab Mokhtari ◽  
Sina Thusek ◽  
Theresa Schneider ◽  
Anna-Leena Sirén ◽  
...  

AbstractMedulloblastoma is the most common high-grade brain tumor in childhood. Medulloblastomas with c-myc amplification, classified as group 3, are the most aggressive among the four disease subtypes resulting in a 5-year overall survival of just above 50%. Despite current intensive therapy regimens, patients suffering from group 3 medulloblastoma urgently require new therapeutic options. Using a recently established c-myc amplified human medulloblastoma cell line, we performed an in-vitro-drug screen with single and combinatorial drugs that are either already clinically approved or agents in the advanced stage of clinical development. Candidate drugs were identified in vitro and then evaluated in vivo. Tumor growth was closely monitored by BLI. Vessel development was assessed by 3D light-sheet-fluorescence-microscopy. We identified the combination of gemcitabine and axitinib to be highly cytotoxic, requiring only low picomolar concentrations when used in combination. In the orthotopic model, gemcitabine and axitinib showed efficacy in terms of tumor control and survival. In both models, gemcitabine and axitinib were better tolerated than the standard regimen comprising of cisplatin and etoposide phosphate. 3D light-sheet-fluorescence-microscopy of intact tumors revealed thinning and rarefication of tumor vessels, providing one explanation for reduced tumor growth. Thus, the combination of the two drugs gemcitabine and axitinib has favorable effects on preventing tumor progression in an orthotopic group 3 medulloblastoma xenograft model while exhibiting a favorable toxicity profile. The combination merits further exploration as a new approach to treat high-risk group 3 medulloblastoma.


2021 ◽  
Vol 84 ◽  
pp. 296
Author(s):  
Gideon Oluniran ◽  
James Blackwell ◽  
Emmanuel Reynaud ◽  
Marcin Krasny ◽  
Niall Colgan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document